Sun Pharma partners with AstraZeneca India over Type II diabetes medicine
Under the agreement, Sun Pharma will promote and distribute dapagliflozin under the brand name 'Oxra'
Author
JP Nadda launches new anti-TB drug
Bedaquiline is being introduced at six identified tertiary care centres across India
Delhi HC extends relief to pharma firms over drug ban
Several companies went to the Delhi High Court to try to get the ban lifted
Indoco Remedies receives USFDA nod for solid dosages plant I in Goa
The plant has a capacity to manufacture 2.2 billion tablets, 32 million bottles of liquid orals, 16 million tubes of creams and…
ERT bags outstanding customer service award
Independent annual survey of customer satisfaction rates ERT one of the best across all industries
BIRAC collaborates with international and national organisations to support innovations
The event was attended by stakeholders from the Department of Biotechnology (DBT), Government, Industry, Academia and foreign…
Govt to make pharma marketing code mandatory
UCPMP will help control unethical practices in the industry
Delhi HC grants relief to Abbott and Macleods
The court issues notice to Ministry of Health and Family Welfare directing it to file status report with regard to the findings of…
SPARC’s Rs 250-crore rights issue to open on March 28
The proceeds of the issue will be utilised for meeting costs related to pharma research and development
Health Ministry bans 344 fixed dose combination drugs
The ban on the drugs comes into immediate effect